Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 141

1.

Hamilton depression rating subscales to predict antidepressant treatment outcome in the early course of treatment.

Helmreich I, Wagner S, König J, Kohnen R, Szegedi A, Hiemke C, Tadić A.

J Affect Disord. 2015 Apr 1;175:199-208. doi: 10.1016/j.jad.2014.12.043. Epub 2014 Dec 24.

PMID:
25638793
2.

Hydrocortisone concentration influences time to clinically significant healing of acute inflammation of the ocular surface and adnexa - results from a double-blind randomized controlled trial.

Sergiyenko N, Sukhina L, Bezdetko P, Kovalenko Y, Nikitin N, Merzbacher M, Gross D, Kohnen R.

BMC Ophthalmol. 2014 May 10;14:64. doi: 10.1186/1471-2415-14-64.

3.

Relation of the International Restless Legs Syndrome Study Group rating scale with the Clinical Global Impression severity scale, the restless legs syndrome 6-item questionnaire, and the restless legs syndrome-quality of life questionnaire.

Allen R, Oertel W, Walters A, Benes H, Schollmayer E, Grieger F, Moran K, Kohnen R.

Sleep Med. 2013 Dec;14(12):1375-80. doi: 10.1016/j.sleep.2013.09.008. Epub 2013 Oct 18.

PMID:
24246378
4.

Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension.

Trenkwalder C, Beneš H, Grote L, García-Borreguero D, Högl B, Hopp M, Bosse B, Oksche A, Reimer K, Winkelmann J, Allen RP, Kohnen R; RELOXYN Study Group.

Lancet Neurol. 2013 Dec;12(12):1141-50. doi: 10.1016/S1474-4422(13)70239-4. Epub 2013 Oct 18. Erratum in: Lancet Neurol. 2013 Dec;12(12):1133.

PMID:
24140442
5.

Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohort.

Mollenhauer B, Trautmann E, Sixel-Döring F, Wicke T, Ebentheuer J, Schaumburg M, Lang E, Focke NK, Kumar KR, Lohmann K, Klein C, Schlossmacher MG, Kohnen R, Friede T, Trenkwalder C; DeNoPa Study Group.

Neurology. 2013 Oct 1;81(14):1226-34. doi: 10.1212/WNL.0b013e3182a6cbd5. Epub 2013 Aug 30.

PMID:
23997153
6.

The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group.

Garcia-Borreguero D, Kohnen R, Silber MH, Winkelman JW, Earley CJ, Högl B, Manconi M, Montplaisir J, Inoue Y, Allen RP.

Sleep Med. 2013 Jul;14(7):675-84. doi: 10.1016/j.sleep.2013.05.016.

7.

Validation of the Multiple Suggested Immobilization Test: A Test for the Assessment of Severity of Restless Legs Syndrome (Willis-Ekbom Disease).

Garcia-Borreguero D, Kohnen R, Boothby L, Tzonova D, Larrosa O, Dunkl E.

Sleep. 2013 Jul 1;36(7):1101-1109.

8.

What treatment works best for restless legs syndrome? Meta-analyses of dopaminergic and non-dopaminergic medications.

Hornyak M, Scholz H, Kohnen R, Bengel J, Kassubek J, Trenkwalder C.

Sleep Med Rev. 2014 Apr;18(2):153-64. doi: 10.1016/j.smrv.2013.03.004. Epub 2013 Jun 6. Erratum in: Sleep Med Rev. 2014 Aug;18(4):367-8.

PMID:
23746768
9.

Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial.

Walter MC, Reilich P, Thiele S, Schessl J, Schreiber H, Reiners K, Kress W, Müller-Reible C, Vorgerd M, Urban P, Schrank B, Deschauer M, Schlotter-Weigel B, Kohnen R, Lochmüller H.

Orphanet J Rare Dis. 2013 Feb 14;8:26. doi: 10.1186/1750-1172-8-26.

10.

The prevalence and characteristics of patients with classic locked-in syndrome in Dutch nursing homes.

Kohnen RF, Lavrijsen JC, Bor JH, Koopmans RT.

J Neurol. 2013 Jun;260(6):1527-34. doi: 10.1007/s00415-012-6821-y. Epub 2013 Jan 11.

PMID:
23306659
11.

European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society.

Garcia-Borreguero D, Ferini-Strambi L, Kohnen R, O'Keeffe S, Trenkwalder C, Högl B, Benes H, Jennum P, Partinen M, Fer D, Montagna P, Bassetti CL, Iranzo A, Sonka K, Williams AM; European Federation of Neurological Societies; European Neurological Society; European Sleep Research Society.

Eur J Neurol. 2012 Nov;19(11):1385-96. doi: 10.1111/j.1468-1331.2012.03853.x. Epub 2012 Sep 3.

PMID:
22937989
12.

Successful treatment of blepharitis with bibrocathol (Posiformin® 2 %).

Bezdetko PA, Sergienko N, Dyomin Y, Korol A, Nikitin N, Merzbacher M, Groß D, Kohnen R.

Graefes Arch Clin Exp Ophthalmol. 2012 Dec;250(12):1869-75. doi: 10.1007/s00417-012-2001-0. Epub 2012 Apr 25.

13.

Augmentation in the treatment of restless legs syndrome with transdermal rotigotine.

Beneš H, García-Borreguero D, Ferini-Strambi L, Schollmayer E, Fichtner A, Kohnen R.

Sleep Med. 2012 Jun;13(6):589-97. doi: 10.1016/j.sleep.2011.09.016. Epub 2012 Apr 13.

PMID:
22503658
14.

Efficacy and safety of dopamine agonists in restless legs syndrome.

Hornyak M, Trenkwalder C, Kohnen R, Scholz H.

Sleep Med. 2012 Mar;13(3):228-36. doi: 10.1016/j.sleep.2011.09.013. Epub 2012 Jan 27. Review.

PMID:
22281001
15.

Psychological distress of patients suffering from restless legs syndrome: a cross-sectional study.

Scholz H, Benes H, Happe S, Bengel J, Kohnen R, Hornyak M.

Health Qual Life Outcomes. 2011 Sep 20;9:73. doi: 10.1186/1477-7525-9-73.

16.

Long-term safety and efficacy of rotigotine transdermal patch for moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension study.

Oertel W, Trenkwalder C, Beneš H, Ferini-Strambi L, Högl B, Poewe W, Stiasny-Kolster K, Fichtner A, Schollmayer E, Kohnen R, García-Borreguero D; SP710 study group.

Lancet Neurol. 2011 Aug;10(8):710-20. doi: 10.1016/S1474-4422(11)70127-2. Epub 2011 Jun 24.

PMID:
21705273
17.

Dopamine agonists for restless legs syndrome.

Scholz H, Trenkwalder C, Kohnen R, Riemann D, Kriston L, Hornyak M.

Cochrane Database Syst Rev. 2011 Mar 16;(3):CD006009. doi: 10.1002/14651858.CD006009.pub2. Review.

PMID:
21412893
18.

Algorithms for the diagnosis and treatment of restless legs syndrome in primary care.

Garcia-Borreguero D, Stillman P, Benes H, Buschmann H, Chaudhuri KR, Gonzalez Rodríguez VM, Högl B, Kohnen R, Monti GC, Stiasny-Kolster K, Trenkwalder C, Williams AM, Zucconi M.

BMC Neurol. 2011 Feb 27;11:28. doi: 10.1186/1471-2377-11-28.

19.

Levodopa for restless legs syndrome.

Scholz H, Trenkwalder C, Kohnen R, Riemann D, Kriston L, Hornyak M.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD005504. doi: 10.1002/14651858.CD005504.pub2. Review.

PMID:
21328278
20.

Parkinson's disease sleep scale--validation of the revised version PDSS-2.

Trenkwalder C, Kohnen R, Högl B, Metta V, Sixel-Döring F, Frauscher B, Hülsmann J, Martinez-Martin P, Chaudhuri KR.

Mov Disord. 2011 Mar;26(4):644-52. doi: 10.1002/mds.23476. Epub 2011 Feb 10.

PMID:
21312275
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk